EARLY PHASE DEVELOPMENT OF CENTRALLY-ACTING DRUGS

Altasciences Clinical Research and Cambridge Cognition are pleased to invite you to this complimentary scientific symposium which is designed for members of the pharmaceutical and biotech communities to discuss and share ideas on early phase development of centrally acting drugs.

Join us as industry experts share in-depth knowledge on the following topics:

• Challenges in Early Phase CNS Clinical Drug Development
• Adaptive Approaches to Optimize Early Phase Clinical Trials
• Cognitive assessments for neuroscience drugs in early phase studies

If you have any questions about this symposium or would like information on obtaining a certificate of completion, contact Sarah Stapleton at sstapleton@altasciences.com or call 913 696-1601.